.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Royal Genetics is stocked at 41 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Farmingdale, Queens, and Astoria. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Royal Genetics concentrated 58.38% of sales in Flower with a month-over-month decline of 13.79%, while Pre-Roll held 19.80% share and fell 29.86% month over month, pointing to demand softening in the inhalables core. Concentrates represented 9.67% share with a sharp 68.57% month-over-month drop, and Vapor Pens at 8.02% share declined 20.30% month over month, whereas Edible, at 4.12% share, grew 14.88% month over month as the only expanding line. With Concentrates named as the top category but carrying just 9.67% share alongside a 68.57% month-over-month retreat, the pattern implies a misalignment between portfolio emphasis and where recent velocity is holding, with mix stability presently anchored by Flower despite its 13.79% month-over-month pullback.
The mix shifts suggest near-term positioning risk in inhalables: combined Flower and Pre-Roll account for 78.18% share yet both contracted month over month by 13.79% and 29.86%, respectively, signaling concentration exposure to categories under pressure. By contrast, Edible’s 14.88% month-over-month growth, even at 4.12% share and a $22.57 average price, indicates a foothold in a counter-cycle segment that could buffer volatility if expanded; meanwhile, Vapor Pens’ 20.30% month-over-month decline at an average price of $43.56 and Concentrates’ 68.57% month-over-month decline at $60.72 suggest price-tier sensitivity and potential assortment gaps. Taken together, the divergence implies Royal Genetics can improve resilience by rebalancing toward slower-cycling formats while tightening premium inhalables where month-over-month elasticity appears elevated.
Competitive Landscape
Royal Genetics is ranked #49 in NY Concentrates in July 2026, with no year-over-year rank reported, down from a peak rank of #31 in May 2026 and trailing leaders as Mfny (Marijuana Farms New York) held #1 with a 48.5% year-over-year sales increase while UMAMII surged from #27 to #3 on 1,736.3% growth; meanwhile, Jetpacks improved from #3 to #2 alongside a 56.8% lift as Nyce moved from #9 to #5 with 67.9% growth, indicating that Royal Genetics’ slide from #31 to #49 during May 2026 to July 2026 leaves it losing relative velocity while fast-rising competitors consolidate demand at the top.
Notable Products
Peanut Butter Breath Pre-Roll (1g) led the movement with a -62.5% month-over-month drop to $1,568 and fell outside the top five while Lemon Tree Pre-Roll (1g) held rank 1 despite a -3.8% decline. Super Boof (3.5g) at rank 2 slid -13.9% and Super Boof Pre-Roll (1g) at rank 3 contracted -13.9%, while Pie Scream (3.5g) countered with a +25.5% rise at rank 5. With four of the top ten in Pre-Rolls but two of those collapsing by more than -60%, the pattern implies the brand’s volume is overexposed to volatile Pre-Roll SKUs and is nudging toward stabilizing Flower to defend the top ranks.
Kush Mints Cold Cure Rosin (1g) plunged -48.7% at rank 9 as Permanent Marker Distillate Disposable (1g) entered at rank 8 with no prior trend, while Lemon Tree (3.5g) eased only -7.5% at rank 4. The juxtaposition of steep declines in Concentrates and Pre-Rolls against moderate Flower softness and one new Vapor Pens entrant suggests Royal Genetics is reallocating attention toward core Flower while testing adjacent inhalable formats to diversify away from SKU-level volatility.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
